Viewing nowCRESBA Tablet 5mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea Hutech Pharma Co., Ltd.

MFDS item code 201702136 · Approved 2017.04.26 · Insurance code 649103420
Improvement of dyslipidemia, inhibition of atherosclerosis progression, and prevention of cardiovascular disease
This medication is used as an adjunct when dietary management and exercise are insufficient to control lipid disorders such as primary hypercholesterolemia and mixed hyperlipidemia. Additionally, it is used as an adjunct in patients with homozygous familial hypercholesterolemia along with dietary therapy or LDL apheresis. This drug lowers total cholesterol and LDL cholesterol levels in patients with hypercholesterolemia, delaying the progression of atherosclerosis, and acts as an adjunct to dietary therapy even in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia. It is also used as an adjunct to dietary therapy in patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and arterial revascularization in adults with a high risk of cardiovascular disease. Overall, this medication is effectively used for various types of hyperlipidemia and in the reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to the LDL cholesterol level, treatment goal, and patient response, and may be increased up to a maximum of 20 mg daily. 3. Older adults: No dosage adjustment is necessary. 4. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Exercise particular caution when administering 20 mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medicine is contraindicated in some of these patients.
Age 10 to 17 years: The usual dosage range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years of age: Safety and efficacy in children under 10 years of age have not been established.
This medication should not be used in certain patients. For example, it should not be administered to patients allergic to any components of this drug, patients with severely impaired liver function, those with muscle disorders, and patients with severe renal impairment. Additionally, it is safe not to use this medication in pregnant or breastfeeding women and in fertile women who are not using appropriate contraception. It should only be administered to women of childbearing potential after adequately explaining the risks of pregnancy and to the fetus. This drug must be used with caution in patients at high risk of muscle disorders, and high-dose administration is contraindicated. For instance, caution is needed in patients with moderate to severe renal impairment, hypothyroidism, a family history of muscle disorders, alcohol abuse, certain races (Asians), and those taking other specific medications. While taking this medication, regular liver function and muscle-related tests should be performed, and if symptoms such as myalgia, muscle weakness, fatigue, or fever occur, a physician should be notified immediately. The medication may be discontinued if severe muscle damage or liver damage is suspected. Moreover, this medication may interact with several other drugs, so any other medications being taken must be disclosed to the healthcare provider. In particular, the risk of muscle damage may increase when used with certain antibiotics, antifungals, immunosuppressants, antivirals, and fibrate medications. This medication should not be used during pregnancy or lactation, and women of childbearing potential should use appropriate contraception. If this medication is taken during pregnancy, it should be discontinued immediately and healthcare personnel should be consulted. In case of overdose, there are no specific antidotes, so treatment should be symptomatic, and careful monitoring of liver function and muscle enzyme levels should be undertaken. This medication is known not to significantly affect the ability to drive or operate machinery, but caution is advised due to potential dizziness. Finally, since this medication contains lactose, patients with lactose intolerance are advised not to use it.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ocular myasthenia, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug rash, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, numbness, paresthesia, chest discomfort, decreased appetite, abdominal distension, syncope, generalized pain
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to avoid exposure to air or moisture and should be kept at a temperature between 1 to 30 degrees Celsius at room temperature. This storage method helps maintain the medication's efficacy and safety.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Korea Hutech Pharma Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.